Other Stories

Full Video

U.S. FDA advisory panel recommends Pfizer vaccine for 5-11 year olds Updated: 2021-10-27 08:18:38 KST

Advisors to the Food and Drug Administration have recommended the FDA approve Pfizer's COVID-19 vaccine for children 5 to 11.
The advisory panel voted unanimously, saying the benefits outweigh the risks.
Last week, Pfizer said the vaccine showed almost 91 percent efficacy in a clinical trial.
Participants were given a dose one-third that given to kids 12 and up.
A final green light will open the door for some 28 million children to get vaccinated.
Inoculations may begin as soon as next week, once the FDA and the CDC make the final call.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.